RLAY
Relay Therapeutics, Inc.
Stock
$18.96+0.47 (+2.54%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$235M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$235M | — |
| 2024 | −$249M | — |
| 2023 | −$300M | — |
| 2022 | −$229M | — |
| 2021 | −$74M | — |
| 2020 | −$102M | — |
| 2019 | −$66M | — |